Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials

EK Avila; M Chamberlain; D Schiff; JC Reijneveld; TS Armstrong; R Ruda; PY Wen; M Weller; JAF Koekkoek; S Mittal; Y Arakawa; A Choucair; J Gonzalez-Martinez; DR Macdonald; R Nishikawa; A Shah; CJ Vecht; P Warren; Martin van den Bent; LM DeAngelis

doi:10.1093/neuonc/now190

Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials

EK Avila, M Chamberlain, D Schiff, JC Reijneveld, TS Armstrong, R Ruda, PY Wen, M Weller, JAF Koekkoek, S Mittal, Y Arakawa, A Choucair, J Gonzalez-Martinez, DR Macdonald, R Nishikawa, A Shah, CJ Vecht, P Warren, Martin van den Bent, LM DeAngelis

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

119 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	12-21
Number of pages	10
Journal	Neuro-Oncology
Volume	19
Issue number	1
DOIs	https://doi.org/10.1093/neuonc/now190
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1093/neuonc/now190

http://hdl.handle.net/1765/108247

Cite this

Avila, EK., Chamberlain, M., Schiff, D., Reijneveld, JC., Armstrong, TS., Ruda, R., Wen, PY., Weller, M., Koekkoek, JAF., Mittal, S., Arakawa, Y., Choucair, A., Gonzalez-Martinez, J., Macdonald, DR., Nishikawa, R., Shah, A., Vecht, CJ., Warren, P., van den Bent, M., & DeAngelis, LM. (2017). Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro-Oncology, 19(1), 12-21. https://doi.org/10.1093/neuonc/now190

@article{1f194c7070aa46ababc0abfd2ca4f3e5,

title = "Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials",

author = "EK Avila and M Chamberlain and D Schiff and JC Reijneveld and TS Armstrong and R Ruda and PY Wen and M Weller and JAF Koekkoek and S Mittal and Y Arakawa and A Choucair and J Gonzalez-Martinez and DR Macdonald and R Nishikawa and A Shah and CJ Vecht and P Warren and \{van den Bent\}, Martin and LM DeAngelis",

year = "2017",

doi = "10.1093/neuonc/now190",

language = "Undefined/Unknown",

volume = "19",

pages = "12--21",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "1",

}

Avila, EK, Chamberlain, M, Schiff, D, Reijneveld, JC, Armstrong, TS, Ruda, R, Wen, PY, Weller, M, Koekkoek, JAF, Mittal, S, Arakawa, Y, Choucair, A, Gonzalez-Martinez, J, Macdonald, DR, Nishikawa, R, Shah, A, Vecht, CJ, Warren, P, van den Bent, M & DeAngelis, LM 2017, 'Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials', Neuro-Oncology, vol. 19, no. 1, pp. 12-21. https://doi.org/10.1093/neuonc/now190

TY - JOUR

T1 - Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials

AU - Avila, EK

AU - Chamberlain, M

AU - Schiff, D

AU - Reijneveld, JC

AU - Armstrong, TS

AU - Ruda, R

AU - Wen, PY

AU - Weller, M

AU - Koekkoek, JAF

AU - Mittal, S

AU - Arakawa, Y

AU - Choucair, A

AU - Gonzalez-Martinez, J

AU - Macdonald, DR

AU - Nishikawa, R

AU - Shah, A

AU - Vecht, CJ

AU - Warren, P

AU - van den Bent, Martin

AU - DeAngelis, LM

PY - 2017

Y1 - 2017

U2 - 10.1093/neuonc/now190

DO - 10.1093/neuonc/now190

M3 - Article

C2 - 27651472

SN - 1522-8517

VL - 19

SP - 12

EP - 21

JO - Neuro-Oncology

JF - Neuro-Oncology

IS - 1

ER -